Next, to test the ability of the TFs predicted by the bioinformatic analysis (ETS-1, GR-β and STAT4; Fig. 2C) to bind the catalase promoter in presence of the T allele, we performed ChIP assay in CLL cells harboring CC or CT/TT genotype. This evidence concerns the gene GZMB and B-cell chronic lymphocytic leukemia.